Related Experiment Video

Updated: Aug 26, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Anti-HLA antibodies in heart transplantation

Elena R Vasilescu1, Eric K Ho, Ludwika de la Torre

  • 1Department of Pathology, Columbia University, 630 West 168 Street, P and S 14-401, New York, NY 10032, USA.

Transplant Immunology
|February 18, 2004
PubMed

Insights

Transplant-related coronary artery disease (TRCAD) is linked to anti-HLA class II antibodies and lymphocyte proliferation in heart transplant recipients. Immune responses targeting HLA-DR antigens appear to drive TRCAD development.

Area of Science:

  • Immunology
  • Cardiology
  • Transplantation Science

Background:

  • Transplant-related coronary artery disease (TRCAD) is a significant long-term complication following heart transplantation.
  • Identifying the immunological factors contributing to TRCAD is crucial for improving patient outcomes.

Purpose of the Study:

  • To investigate the association between TRCAD development and specific immunological risk factors in adult heart allograft recipients.
  • To elucidate the roles of HLA mismatches, anti-HLA antibodies, and cellular immune responses in TRCAD pathogenesis.

Main Methods:

  • Analysis of 285 adult heart allograft recipients monitored for at least two years.
  • Assessment of HLA mismatches, anti-HLA antibody production, graft-infiltrating lymphocyte proliferation (ex-vivo with IL-2), and acute rejection episodes.
  • Correlation analysis between these factors and TRCAD development.

Main Results:

  • A significant correlation was observed between TRCAD and the generation of anti-HLA class II antibodies.
  • Increased ex-vivo proliferation of graft-infiltrating lymphocytes in IL-2-containing medium was also significantly correlated with TRCAD.
  • Humoral and cellular immune responses directed against HLA-DR antigens on the graft appear to be key drivers of TRCAD.

Conclusions:

  • Anti-HLA class II antibodies and cellular immune responses to HLA-DR antigens are significant risk factors for TRCAD development in heart transplant recipients.
  • These findings highlight the importance of monitoring and managing humoral and cellular immunity to prevent TRCAD.

More Related Videos

Murine Heterotopic Heart Transplant Technique10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...